Bristol-Myers Squibb
This article was originally published in The Tan Sheet
Executive Summary
Sales of Boost adult nutritional supplement increase 16% to $23 mil. in the first quarter, BMS announces April 21. Overall nutritional sales were flat at $449 mil. "as domestic sales growth of 6% was offset by the adverse effects of the economic downturn in Asian markets," the firm notes. Infant formula sales rose 3% to $318 mil., and Enfamil, Bristol's best-selling formula brand, had a 5% sales increase to $179 mil. Specialty infant formula sales were flat at $11 mil., including Nutramigen, which had an 11% sales rise to $32 mil